- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 19.05. | NT PHARMA (01011): CHANGE OF CHIEF EXECUTIVE OFFICER | 1 | HKEx | ||
| CHINA NT PHARMA Aktie jetzt für 0€ handeln | |||||
| 09.05. | NT PHARMA (01011): VOLUNTARY ANNOUNCEMENT | 1 | HKEx | ||
| 30.04. | NT PHARMA (01011): NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED HOLDER | - | HKEx | ||
| 30.04. | NT PHARMA (01011): NOTIFICATION LETTER AND REQUEST FORM TO REGISTERED SHAREHOLDER | - | HKEx | ||
| 30.04. | NT PHARMA (01011): FORM OF PROXY FOR USE AT ANNUAL GENERAL MEETING | - | HKEx | ||
| 30.04. | NT PHARMA (01011): NOTICE OF ANNUAL GENERAL MEETING | 1 | HKEx | ||
| 30.04. | NT PHARMA (01011): PROPOSED GRANTING OF GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES, PROPOSED RE-ELECTION OF RETIRING DIRECTORS AND NOTICE ... | - | HKEx | ||
| 30.04. | NT PHARMA (01011): ANNUAL REPORT 2024 | - | HKEx | ||
| 29.04. | NT PHARMA (01011): CLARIFICATION ANNOUNCEMENT - MAJOR TRANSACTION IN RELATION TO ACQUISITION OF 100% OF THE ISSUED SHARES IN THE TARGET COMPANIES INVOLVING ... | 1 | HKEx | ||
| 28.04. | NT PHARMA (01011): MAJOR TRANSACTION IN RELATION TO ACQUISITION OF 100% OF THE ISSUED SHARES IN THE TARGET COMPANIES INVOLVING THE ISSUE OF CONSIDERATION ... | - | HKEx | ||
| 31.03. | NT PHARMA (01011): ANNOUNCEMENT OF AUDITED ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2024 | - | HKEx | ||
| 20.03. | NT PHARMA (01011): CLARIFICATION ANNOUNCEMENT IN RELATION TO DATE OF BOARD MEETING | - | HKEx | ||
| 19.03. | NT PHARMA (01011): DATE OF BOARD MEETING | 1 | HKEx | ||
| 21.02. | NT PHARMA (01011): NEXT DAY DISCLOSURE RETURN | 1 | HKEx | ||
| 21.02. | NT PHARMA (01011): COMPLETION OF CONNECTED TRANSACTION IN RELATION TO LOAN CAPITALIZATION INVOLVING SUBSCRIPTION OF SHARES UNDER SPECIFIC MANDATE | - | HKEx | ||
| 17.02. | NT PHARMA (01011): (1) POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON 17 FEBRUARY 2025; AND (2) GRANT OF WHITEWASH WAIVER | 2 | HKEx | ||
| 04.02. | NT PHARMA (01011): SUPPLEMENTAL ANNOUNCEMENT | - | HKEx | ||
| 28.01. | NT PHARMA (01011): DESPATCH OF THE CIRCULAR IN RELATION TO (1) CONNECTED TRANSACTION IN RELATION TO LOAN CAPITALIZATION INVOLVING SUBSCRIPTION OF SHARES ... | 1 | HKEx | ||
| 27.01. | NT PHARMA (01011): NOTIFICATION LETTER AND REPLY FORM TO REGISTERED SHAREHOLDER | 2 | HKEx | ||
| 27.01. | NT PHARMA (01011): NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED HOLDER | 1 | HKEx |
1 2 Weiter >>
26 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| AURORA CANNABIS | 5,030 | +0,20 % | Aurora Cannabis Inc (3): Aurora Cannabis launches IndiMed Tempo 22 | ||
| CANOPY GROWTH | 1,498 | +0,67 % | Canopy Growth has price target chopped at Roth | ||
| HALO COLLECTIVE | 0,010 | 0,00 % | Waters Corporation Buys Halo Labs | WASHINGTON (dpa-AFX) - Waters Corporation (WAT), an analytical instruments and software firm, said on Wednesday that it has acquired Halo Labs, a company focused on specialized imaging technologies... ► Artikel lesen | |
| TILRAY BRANDS | 0,357 | +0,11 % | Tilray Brands Inc: Tilray Brands to be deleted from S&P/TSX Composite | ||
| DIGICANN VENTURES | 0,004 | 0,00 % | Digicann Ventures Inc.: Digicann Ventures Provides Update Regarding Proposed RTO Transaction | / Not for distribution to U.S. news wire services or for dissemination in the United States / VANCOUVER, British Columbia, April 22, 2025 (GLOBE NEWSWIRE) -- Digicann Ventures Ltd. ("Digicann" or... ► Artikel lesen | |
| WPD PHARMACEUTICALS | 0,002 | 0,00 % | CSE Bulletin: Consolidation - WPD Pharmaceuticals Inc. (WBIO) | le 23 décembre/December 2024
WPD Pharmaceuticals Inc. has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-consolidated common share for every twenty-five... ► Artikel lesen | |
| SINOPHARM | 2,110 | +0,19 % | Kurs der Sinopharm Group fällt ab (2,054 €) | Am Aktienmarkt notiert der Anteilsschein der Sinopharm Group aktuell ein wenig leichter. Die Aktie notiert derzeit bei 2,05 Euro. Für Inhaber der Sinopharm Group ist der heutige Handelstag bisher nicht... ► Artikel lesen | |
| INDIVA | 0,016 | -100,00 % | Indiva Ltd: Indiva to be delisted from NEX | ||
| CSPC PHARMA | 0,988 | +1,58 % | Dividendenbekanntmachungen (04.06.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADESSO SE DE000A0Z23Q5 - 0,75 EUR AGEAS SA/NV BE0974264930 - 2 EUR AIR LEASE CORPORATION US00912X3026 0,22 USD 0,1934 EUR ANALOG... ► Artikel lesen | |
| ORAMED PHARMACEUTICALS | 1,910 | -2,20 % | Oramed Pharmaceuticals Inc.: Oramed Pharmaceuticals Announces $36.9 Million Investment and Strategic Collaboration with Alpha Tau Medical | Oramed leverages its strategic capital markets expertise to support Alpha Tau's breakthrough cancer therapy technology
Accelerating multiple late-stage cancer therapies... ► Artikel lesen | |
| ADASTRA | 0,152 | 0,00 % | Adastra Holdings Ltd.: Adastra Holdings Announces New Director | Langley, British Columbia--(Newsfile Corp. - March 3, 2025) - Adastra Holdings Ltd. (CSE: XTRX) (FSE: D2EP) ("Adastra" or the "Company"), a leading cannabis processor and producer of two top Canadian... ► Artikel lesen | |
| CATALYST PHARMACEUTICALS | 22,750 | +0,22 % | Catalyst Pharmaceuticals, Inc.: Catalyst Pharmaceuticals Announces Appointment of William T. Andrews, MD, FACP as Chief Medical Officer | CORAL GABLES, Fla., June 02, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX) today announced the appointment of William (Will) T. Andrews, MD, FACP... ► Artikel lesen | |
| BAYER | 26,435 | +0,02 % | Bayer, Deutsche Bank, Volkswagen und Co: Unterbewertete deutsche Aktien mit Comeback-Potenzial | Die Rheinmetall-Aktie ist in diesem Jahr bereits um 200 Prozent gestiegen. Doch nicht jede deutsche Aktie kann eine solche Performance aufweisen. Wie es bei Bayer, Deutsche Bank, Volkswagen und Co steht... ► Artikel lesen | |
| MERCK KGAA | 115,20 | -0,17 % | JPMORGAN stuft MERCK KGAA auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Merck KGaA mit einem Kursziel von 155 Euro auf "Overweight" belassen. Die auf der Asco-Krebsforschertagung präsentierten Studiendaten... ► Artikel lesen | |
| GSK | 18,050 | -0,03 % | BERENBERG stuft GSK auf 'Hold' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat GSK nach gutem Lauf bei unverändertem Kursziel von 1600 Pence von "Buy" auf "Hold" abgestuft. Die Kursentwicklung des Pharmakonzerns sei in... ► Artikel lesen |
Das Unternehmen CHINA NT PHARMA GROUP CO LTD kann der Branche Pharma zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CHINA NT PHARMA GROUP CO LTD finden Sie auf Wallstreet Online.